🔥Telegram İfşa

📢📢New drug assessment report: dapagliflozin in chronic kidney disease navarra.es/home_en/Temas/…

📢📢New drug assessment report: vericiguat in heart failure

We support the prohibition of Direct to Consumer Advertising of Prescription Medicines (DTCA-PM) in New Zealand cmc.org.nz/dtca-open-lett…

📢📢New drug assessment report📢📢EMPAGLIFLOZIN FOR SYMPTOMATIC, CHRONIC HEART FAILURE. Yes, but... for much selected patients. navarra.es/NR/rdonlyres/C…

(dtbn) Long-acting injectable antipsychotics in schizophrenia 💉💉 navarra.es/home_en/Temas/…

📢📢New drug assessment report📢📢 Bempedoic Acid and Bempedoic Acid/Ezetimibe: a mystery for the treatment of hypercholesterolaemia navarra.es/home_en/Temas/…

Long-term effectiveness and safety of tolvaptan in autosomal dominant ... sciencedirect.com/science/articl…

📢📢New drug assessment report📢📢 Use of fluid therapy in clinical practice doi.org/10.54095/BITN2… BIT Navarra

📢📢New drug assessment report📢📢 Icosapent Ethil (Omega-3) for hypertriglyceridemia navarra.es/home_en/Temas/…

📢📢New drug assessment report 📢📢 Dapagliflozin for heart failure with mildly reduced or preserved ejection fraction navarra.es/NR/rdonlyres/B…

📢New drug assessment report: FINERENONE IN CHRONIC KIDNEY DISEASE ASSOCIATED WITH TYPE 2 DIABETES navarra.es/home_en/Temas/…

(Cochrane Library) Blood pressure targets for hypertension in people with chronic renal disease cochranelibrary.com/cdsr/doi/10.10…

📢📢Glucagon-like peptide 1 receptor agonists (GLP1a) and the problem of obesity doi.org/10.54095/BITN2… BIT Navarra Salud - Osasuna

📢📢Surrogate outcomes and fast-track drug approval. Towards reversing the burden of proof? doi.org/10.54095/BITN2… BIT Navarra Salud - Osasuna

📢📢 New drug assessment report 📢📢 Tirzepatide. Unknowns regarding its efficacy in morbidity and mortality Salud - Osasuna navarra.es/NR/rdonlyres/8…

📢📢Beyond statins: evidence for other lipid-lowering drugs in patients with atherosclerotic cardiovascular disease doi.org/10.54095/BITN2… BIT Navarra Salud - Osasuna

📢📢 Therapeutic personalisation I: practical aspects of pharmacokinetic monitoring 📢📢 doi.org/10.54095/BITN2… Maria Calvo Arbeloa Salud - Osasuna